Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-08-17 08:00 am Purchase | 2023-08-09 | 13D | Anika Therapeutics, Inc. ANIK | Caligan Partners LP | 902,086 6.200% | 902,086 (New Position) | Filing History |
| 2023-02-14 10:33 am Sale | 2022-12-31 | 13G | Anika Therapeutics, Inc. ANIK | AMERIPRISE FINANCIAL INC AMP | 181,943 1.250% | -805,790 (-81.58%) | Filing History |
| 2023-02-10 2:42 pm Purchase | 2023-02-14 | 13G | Anika Therapeutics, Inc. ANIK | Dimensional Fund Advisors LP | 959,746 6.600% | 103,622 (+12.10%) | Filing History |
| 2023-02-10 1:24 pm Purchase | 2022-12-31 | 13G | Anika Therapeutics, Inc. ANIK | Trigran Investments, Inc. | 1,564,541 10.700% | 71,296 (+4.77%) | Filing History |
| 2023-02-09 11:07 am Purchase | 2022-12-30 | 13G | Anika Therapeutics, Inc. ANIK | The Vanguard Group | 983,768 6.730% | 17,855 (+1.85%) | Filing History |
| 2023-02-08 09:40 am Purchase | 2022-12-31 | 13G | Anika Therapeutics, Inc. ANIK | STATE STREET CORP STT | 908,867 6.220% | 110,299 (+13.81%) | Filing History |
| 2023-01-26 08:52 am Unchanged | 2022-12-31 | 13G | Anika Therapeutics, Inc. ANIK | BlackRock Inc. BLK | 2,526,802 17.300% | 0 (Unchanged) | Filing History |
| 2023-01-20 09:43 am Purchase | 2022-12-31 | 13G | Anika Therapeutics, Inc. ANIK | BlackRock Inc. BLK | 2,526,802 17.300% | 168,185 (+7.13%) | Filing History |
| 2022-10-06 5:58 pm Purchase | 2022-09-20 | 13G | Anika Therapeutics, Inc. ANIK | Trigran Investments, Inc. | 1,493,245 10.200% | 1,493,245 (New Position) | Filing History |
| 2022-06-09 4:15 pm Sale | 2022-05-31 | 13G | Anika Therapeutics, Inc. ANIK | Kayne Anderson Rudnick Investment Management, LLC | 627,321 4.310% | -840,189 (-57.25%) | Filing History |
| 2022-02-14 12:27 pm Sale | 2021-12-31 | 13G | Anika Therapeutics, Inc. ANIK | AMERIPRISE FINANCIAL INC AMP | 987,733 6.840% | -16,375 (-1.63%) | Filing History |
| 2022-02-11 6:54 pm Sale | 2021-12-31 | 13G | Anika Therapeutics, Inc. ANIK | Avidity Partners Management LP | 0 0.000% | -731,000 (Position Closed) | Filing History |
| 2022-02-11 6:27 pm Sale | 2021-12-31 | 13G | Anika Therapeutics, Inc. ANIK | Kayne Anderson Rudnick Investment Management, LLC | 1,467,510 10.170% | -78,753 (-5.09%) | Filing History |
| 2022-02-10 3:13 pm Sale | 2021-12-31 | 13G | Anika Therapeutics, Inc. ANIK | Renaissance Technologies LLC | 683,417 4.730% | -125,700 (-15.54%) | Filing History |
| 2022-02-10 2:22 pm Sale | 2021-12-31 | 13G | Anika Therapeutics, Inc. ANIK | STATE STREET CORP STT | 798,568 5.530% | -22,178 (-2.70%) | Filing History |
| 2022-02-09 3:24 pm Purchase | 2021-12-31 | 13G | Anika Therapeutics, Inc. ANIK | The Vanguard Group | 965,913 6.690% | 31,631 (+3.39%) | Filing History |
| 2022-02-08 3:52 pm Sale | 2022-02-14 | 13G | Anika Therapeutics, Inc. ANIK | Dimensional Fund Advisors LP | 856,124 5.900% | -27,992 (-3.17%) | Filing History |
| 2022-01-27 1:59 pm Unchanged | 2021-12-31 | 13G | Anika Therapeutics, Inc. ANIK | BlackRock Inc. BLK | 2,358,617 16.300% | 0 (Unchanged) | Filing History |
| 2022-01-25 6:45 pm Purchase | 2021-12-31 | 13G | Anika Therapeutics, Inc. ANIK | BlackRock Inc. BLK | 2,358,617 16.300% | 108,327 (+4.81%) | Filing History |
| 2021-02-16 12:01 pm Purchase | 2020-12-31 | 13G | Anika Therapeutics, Inc. ANIK | Avidity Partners Management LP | 731,000 5.100% | 731,000 (New Position) | Filing History |